GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $3.88 million. The enterprise value is $5.79 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 10.37 million shares outstanding. The number of shares has increased by 36.63% in one year.
| Current Share Class | 10.37M |
| Shares Outstanding | 10.37M |
| Shares Change (YoY) | +36.63% |
| Shares Change (QoQ) | +2.18% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 0.46% |
| Float | 10.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -0.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -39.73 |
Financial Efficiency
Return on equity (ROE) is -1,943.32% and return on invested capital (ROIC) is -412.37%.
| Return on Equity (ROE) | -1,943.32% |
| Return on Assets (ROA) | -204.31% |
| Return on Invested Capital (ROIC) | -412.37% |
| Return on Capital Employed (ROCE) | 346.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.49M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.37% in the last 52 weeks. The beta is -0.38, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | -0.38 |
| 52-Week Price Change | -98.37% |
| 50-Day Moving Average | 2.92 |
| 200-Day Moving Average | 29.22 |
| Relative Strength Index (RSI) | 25.94 |
| Average Volume (20 Days) | 4,093,475 |
Short Selling Information
The latest short interest is 657,536, so 6.34% of the outstanding shares have been sold short.
| Short Interest | 657,536 |
| Short Previous Month | 1.22M |
| Short % of Shares Out | 6.34% |
| Short % of Float | 6.49% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.11M |
| Pretax Income | -7.56M |
| Net Income | -14.92M |
| EBITDA | -13.10M |
| EBIT | -13.11M |
| Earnings Per Share (EPS) | -$57.77 |
Full Income StatementBalance Sheet
The company has $346,000 in cash and $2.26 million in debt, giving a net cash position of -$1.91 million or -$0.18 per share.
| Cash & Cash Equivalents | 346,000 |
| Total Debt | 2.26M |
| Net Cash | -1.91M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | -4.02M |
| Book Value Per Share | -13.94 |
| Working Capital | -3.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.40 million and capital expenditures -$104,000, giving a free cash flow of -$11.51 million.
| Operating Cash Flow | -11.40M |
| Capital Expenditures | -104,000 |
| Free Cash Flow | -11.51M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |